Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

74.75 +0.17 (+0.22%)
Streaming Delayed Price Updated: 3:02 PM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
News headline image
Boston Scientific Reports Higher Profit Margins In Q2, Lifts Guidance ↗
Boston Scientific beats Q2 estimates, posts 22.8% revenue growth, and raises full-year outlook on strong cardiovascular and MedSurg performance. 
Via Benzinga
News headline image
Boston Scientific Eyes Breakout On Strong Second Quarter, Guidance ↗
The company issued a positive outlook for 2025 that includes better-than-expected sales growth and adjusted profit. 
Via Investor's Business Daily
News headline image
Boston Scientific (NYSE:BSX) Reports Bullish Q2, Guides for Strong Sales Next Quarter
Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 22.8% year on year to $5.06 billion. Guidance for next quarter’s... 
Via StockStory
News headline image
Earnings Scheduled For July 23, 2025 ↗
 
Via Benzinga
News headline image
What To Expect From Boston Scientific’s (BSX) Q2 Earnings
Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday before market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
Is Boston Scientific Gaining or Losing Market Support? ↗
 
Via Benzinga
News headline image
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
P/E Ratio Insights for Boston Scientific ↗
 
Via Benzinga
News headline image
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Contender in Growth and Momentum Investing ↗
Boston Scientific Corp (NYSE:BSX) shows strong technical and growth momentum, meeting Minervini Trend Template criteria with solid earnings and revenue expansion. A potential breakout candidate for... 
Via Chartmill
News headline image
BOSTON SCIENTIFIC CORP (NYSE:BSX) - A Strong Technical Setup in the Medical Device Sector ↗
Boston Scientific Corp (NYSE:BSX) shows strong technicals and a high-quality setup, making it a breakout candidate. The stock's consolidation near resistance and institutional support suggest potential... 
Via Chartmill
News headline image
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A High Growth Momentum Stock with Strong Technical Setup ↗
BOSTON SCIENTIFIC CORP (NYSE:BSX) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has solid EPS growth, margin expansion, and... 
Via Chartmill
News headline image
$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
1 Large-Cap Stock for Long-Term Investors and 2 to Ignore
Via StockStory
News headline image
1 Safe-and-Steady Stock to Research Further and 2 to Turn Down
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Contender in Growth and Momentum ↗
Boston Scientific Corp (NYSE:BSX) shows strong technical and fundamental growth, fitting Minervini’s trend template with high earnings momentum and improving margins. A top pick for momentum... 
Via Chartmill
News headline image
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A High Growth Momentum Stock with Strong Technical Setup ↗
Boston Scientific Corp (NYSE:BSX) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has solid support levels and consolidation... 
Via Chartmill
News headline image
1 Growth Stock with All-Star Potential and 2 to Keep Off Your Radar
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s... 
Via StockStory
News headline image
Leerink Initiates Boston Scientific Coverage With ‘Outperform’ Rating: Stock Rallies But Retail’s Not Overly Excited ↗
The new price target of $118 represents an upside of over 18% from the stock’s closing price of $99.74 on Friday. 
Via Stocktwits
News headline image
This Boston Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
Deep Dive Into Boston Scientific Stock: Analyst Perspectives (13 Ratings) ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A High-Growth Momentum Stock with Strong Technical Setup ↗
Boston Scientific Corp (NYSE:BSX) combines strong earnings momentum, expanding margins, and a bullish technical setup, making it a candidate for high-growth investors. 
Via Chartmill
News headline image
3 Market-Beating Stocks with Competitive Advantages
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the... 
Via StockStory
News headline image
Michael Mahoney Turned Boston Scientific Into A Medical Tech Empire ↗
Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted. 
Via Investor's Business Daily
News headline image
Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook ↗
Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to meet 2025 sales. 
Via Benzinga
News headline image
Boston Scientific Discontinues Worldwide Sales Of Acurate Aortic Valve Systems: But Retail Sentiment Brightens ↗
The company said in a regulatory filing that the decision was made in light of increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals... 
Via Stocktwits
News headline image
How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott ↗
The company said the regulatory path forward for one of its key systems is too murky to pursue. 
Via Investor's Business Daily
News headline image
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Growth Stock with Technical Breakout Potential ↗
Boston Scientific Corp (NYSE:BSX) shows strong growth fundamentals and a bullish technical setup, making it a compelling candidate for growth investors. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.